Portions of this exhibit marked [*] are requested to be treated confidentially. DCVAX-DIRECT MANUFACTURING AND SERVICES AGREEMENTServices Agreement • May 15th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Services Agreement (this “Agreement”) is entered into, effective as of January 17, 2014(the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
Portions of this exhibit marked [*] are requested to be treated confidentially. ANCILLARY SERVICES AGREEMENTAncillary Services Agreement • May 15th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Ancillary Services Agreement (this “Agreement”) is entered into, effective as of January 17, 2014 (the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
MANUFACTURING EXPANSION SERVICES AGREEMENTManufacturing Services Agreement • May 15th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Services Agreement (this “Agreement”) is entered into, effective as of January 17, 2014 (the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
Portions of this exhibit marked [*] are requested to be treated confidentially. DCVAX®-L MANUFACTURING AND SERVICES AGREEMENTServices Agreement • May 15th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Amended and Restated Services Agreement (this “Agreement”), originally dated April 1, 2011 is entered into, effective as of January 17, 2014 (the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
